Prevalence of type 1 Brugada ECG pattern after administration of Class 1C drugs in patients with type 1 myotonic dystrophy: Myotonic dystrophy as a part of the Brugada syndrome

Heart Rhythm

Volumn 11, Issue 10, 2014, Pages 1721-1727

  Maury, Philippe ^a   Audoubert, Mathieu ^a   Cintas, Pascal ^a   Rollin, Anne ^a   Duparc, Alexandre ^a   Mondoly, Pierre ^a   Chiriac, Ana Maria ^b   Acket, Blandine ^a   Zhao, Xinran ^b   Pasquié, Jean Luc ^b   Cardin, Christelle ^a   Delay, Marc ^a   Sadron, Marie ^a   Carrié, Didier ^a   Galinier, Michel ^a   Davy, Jean Marc ^b   Arne Bès, Marie Christine ^a   Raczka, Franck ^b  

^a CHU RANGUEIL   (France)

^b HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AJMALINE; FLECAINIDE; VOLTAGE GATED SODIUM CHANNEL BLOCKING AGENT;

ADULT; ARTICLE; BRADYCARDIA; BRUGADA SYNDROME; CLINICAL ARTICLE; DEVICE FAILURE; ECG ABNORMALITY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART BUNDLE BRANCH BLOCK; HEART DEPOLARIZATION; HEART ELECTROPHYSIOLOGY; HEART LEFT BUNDLE BRANCH BLOCK; HEART RATE; HEART REPOLARIZATION; HEART RIGHT BUNDLE BRANCH BLOCK; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE CONDUCTION; HEART VENTRICLE FIBRILLATION; HOLTER MONITORING; HUMAN; HYPOKALEMIA; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INHERITANCE; MALE; MEDICAL DEVICE COMPLICATION; MYOTONIC DYSTROPHY; P WAVE; PACEMAKER; PACEMAKER ELECTRODE; PACEMAKER IMPLANTATION; PR INTERVAL; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROVOCATION TEST; QT INTERVAL; SECOND DEGREE ATRIOVENTRICULAR BLOCK; SEX DIFFERENCE; SIGNAL AVERAGED ELECTROCARDIOGRAPHY; ST SEGMENT ELEVATION; T WAVE; TRANSTHORACIC ECHOCARDIOGRAPHY; CHEMICALLY INDUCED; CLINICAL TRIAL; COMPLICATION; DEATH, SUDDEN, CARDIAC; DRUG EFFECTS; ELECTROCARDIOGRAPHY; FRANCE; INCIDENCE; MULTICENTER STUDY; PATHOPHYSIOLOGY; SURVIVAL RATE; TRENDS;

ADULT; AJMALINE; BRUGADA SYNDROME; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; FEMALE; FLECAINIDE; FOLLOW-UP STUDIES; FRANCE; HUMANS; INCIDENCE; MALE; MYOTONIC DYSTROPHY; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE; VOLTAGE-GATED SODIUM CHANNEL BLOCKERS;

EID: 84922633743     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2014.07.011     Document Type: Article

References (33)

1. J.D. Brook, M.E. McCuffach, H.G. Harley, A.J. Buckler, D. Church, and H. Aburatani Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member Cell 68 1992 799 808
2. M.F. Philips, and P.S. Harper Cardiac disease in myotonic dystrophy Cardiovasc Res 33 1997 13 22
3. W.J. Groh, M.R. Groh, and C. Saha Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1 N Engl J Med 358 2008 2688 2697
4. K. Wahbi, C. Meune, R. Porcher, H.M. Bécane, A. Lazarus, P. Laforêt, T. Stojkovic, A. Béhin, H. Radvanyi-Hoffmann, B. Eymard, and D. Duboc Electrophysiological study with prophylactic pacing and survival in adults with myotonic dystrophy and conduction system disease JAMA 307 2012 1292 1301
5. A.H. Ha, M.A. Tarnopolsky, T.G. Bergstra, G.M. Nair, A. Al-Qubbany, and J.S. Healey Predictors of atrio-ventricular conduction disease, long-term outcomes in patients with myotonic dystrophy types I and II Pacing Clin Electrophysiol 35 2012 1262 1269
6. A. Lazarus, J. Varin, D. Babuty, F. Anselme, J. Coste, and D. Duboc Long-term follow-up of arrhythmias in patients with myotonic dystrophy treated by pacing: a multicenter diagnostic pacemaker study J Am Coll Cardiol 40 2002 1645 1652
7. S. Mörner, P. Lindqvist, C. Mellberg, B.O. Olofsson, C. Backman, M. Henein, D. Lundblad, and H. Forsberg Profound cardiac conduction delay predicts mortality in myotonic dystrophy type 1 J Intern Med 268 2010 59 65
8. P. Kaminsky, B. Brembilla-Perrot, L. Pruna, M. Poussel, and B. Chenuel Age, conduction defects and restrictive lung disease independently predict cardiac events and death in myotonic dystrophy Int J Cardiol 162 2013 172 178
9. V. Laurent, S. Pellieux, P. Corcia, P. Magro, B. Pierre, L. Fauchier, M. Raynaud, and D. Babuty Mortality in myotonic dystrophy patients in the area of prophylactic pacing devices Int J Cardiol 150 2011 54 58
10. A. Dello Russo, F. Mangiola, and P. Della Bella Risk of arrhythmias in myotonic dystrophy: trial design of the RAMYD study J Cardiovasc Med (Hagerstown) 10 2009 51 58
11. L.E. Grigg, W. Chan, H.G. Mond, J.K. Vohra, and W.F. Downey Ventricular tachycardia and sudden death in myotonic dystrophy: clinical, electrophysiologic and pathologic features J Am Coll Cardiol 6 1985 254 256
12. D. Bhakta, C. Shen, J. Kron, A.E. Epstein, R.M. Pascuzzi, and W.J. Groh Pacemaker and implantable cardioverter-defibrillator use in a US myotonic dystrophy type 1 population J Cardiovasc Electrophysiol 22 2011 1369 1375
13. S. Hiromasa, T. Ikeda, K. Kubota, N. Hattori, H. Coto, C. Maldonado, and J. Kupersmith Ventricular tachycardia and sudden death in myotonic dystrophy Am Heart J 115 1988 914 915
14. C.J. Rainirez, D.A. Rodriguez, V.M. Velasco, and F. Rosas Myotonic dystrophy and bundle branch reentrant tachycardia Rev Esp Cardiol 55 2002 1093 1097
15. A. Lagrange, P. Lagrange, S. Boveda, E. Espaliat, J.P. Penot, P. Defaye, T. Arentz, F. Tabaraud, P. Virot, and P. Blanc Ventricular tachycardia by branch to branch re-entry. Familial case with Steinert disease Arch Mal Coeur Vaiss 93 2000 743 749
16. J.L. Merino, J.R. Carmona, Fernandez-Lozano 1, R. Peinado, N. Basterra, and J.A. Sobrino Mechanisms of sustained ventricular tachycardia in myotonic dystrophy: implications for catheter ablation Circulation 98 1998 541 546
17. S. Bharati, F.T. Bump, R. Bauernfeind, and M. Lev Dystrophica myotonia: correlative electrocardiographic, electrophysiologic, and conduction system study Chest 86 1984 444 450
18. A. Kamara, S.S. Nijjer, A.K. Ghosh, R. Grocott-Mason, and S. Dubrey Lesson of the month (1). Myotonic dystrophy and out-of-hospital arrest Clin Med 10 2010 630 632
19. S.G. Priori, A.A. Wilde, and M. Horie HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes Heart Rhythm 10 2013 1932 1963
20. B.O. Olofsson, H. Forsberg, S. Andersson, P. Bjerle, A. Henriksson, and I. Wedin Electrocardiographic findings in myotonic dystrophy Br Heart J 59 1988 47 52
21. V. Rakocević-Stojanović, S. Pavlović, D. Lavrnić, and S. Apostolski Frequency of electrocardiographic changes in patients with myotonic dystrophy Srp Arh Celok Lek 123 1995 247 250
22. Wahbi K1, V. Algalarrondo, H.M. Bécane, V. Fressart, C. Beldjord, K. Azibi, A. Lazarus, N. Berber, H. Radvanyi-Hoffman, T. Stojkovic, A. Béhin, P. Laforêt, B. Eymard, S. Hatem, and D. Duboc Brugada syndrome and abnormal splicing of SCN5A in myotonic dystrophy type 1 Arch Cardiovasc Dis 106 2013 635 653
23. J.S. Hermida, S. Jandaud, J.L. Lemoine, C. Rodriguez-Lafrasse, J. Delonca, C. Bertrand, G. Jarry, J. Rochette, and J.L. Rey Prevalence of drug-induced electrocardiographic pattern of the Brugada syndrome in a healthy population Am J Cardiol 94 2004 230 233
24. S. Rudnik-Schöneborn, M. Schaupp, A. Lindner, W. Kress, E. Schulze-Bahr, S. Zumhagen, M. Elbracht, and K. Zerres Brugada-like cardiac disease in myotonic dystrophy type 2: report of two unrelated patients Eur J Neurol 18 2010 191 194
25. R.F. Otten, J.A. Scherschel, J.C. Lopshire, D. Bhakta, R.M. Pascuzzi, and W.J. Groh Arrhythmia exacerbation after sodium channel blockade in myotonic dystrophy type 1 Muscle Nerve 40 2009 901 902
26. C. Franke, H. Hatt, P.A. Iaizzo, and F. Lehmann-Horn Characteristics of Na+ channels and Cl-conductance in resealed muscle fibre segments from patients with myotonic dystrophy J Physiol 425 1990 391 405
27. J.W. Day, and L.P. Ranum RNA pathogenesis of the myotonic dystrophies Neuromuscul Disord 15 2005 5 16
28. C. Antzelevitch, P. Brugada, J. Brugada, R. Brugada, K. Nademanee, and J. Towbin The Brugada syndrome A.J. Camm, Clinical Approaches to Tachyarrhythmias Volume 10 1999 Futura Publishing Company Armonk, NY 73
29. K. Nademanee, G. Veerakul, P. Chandanamattha, L. Chaothawee, A. Ariyachaipanich, K. Jirasirirojanakorn, K. Likittanasombat, K. Bhuripanyo, and T. Ngarmukos Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium Circulation 123 2011 1270 1279
30. J.L. Merino, J.R. Carmona, I. Fernández-Lozano, R. Peinado, N. Basterra, and J.A. Sobrino Mechanisms of sustained ventricular tachycardia in myotonic dystrophy: implications for catheter ablation Circulation 98 1998 541 546
31. E.L. Logigian, W.B. Martens, R.T. Moxley 4th, M.P. McDermott, N. Dilek, A.W. Wiegner, A.T. Pearson, C.A. Barbieri, C.L. Annis, C.A. Thornton, and R.T. Moxley III Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1 Neurology 74 2010 1441 1448
32. B. Fazio Steinert's myotonic dystrophy. Attempts at therapy Minerva Med 79 1988 137-134
33. A. Lazarus, J. Varin, Z. Ounnoughene, H. Radvanyi, C. Junien, J. Coste, P. Laforet, B. Eymard, H.M. Becane, S. Weber, and D. Duboc Relationships among electrophysiological findings and clinical status, heart function, and extent of DNA mutation in myotonic dystrophy Circulation 99 1999 1041 1046